A recent paper suggests that keratin 9 may serve as a biomarker for Alzheimer disease, be implicated in polycystic ovary syndrome (Richens et al. 2016; Kim et al. 2013) and may serve as a marker of metastatic hepatocellular carcinoma (Fu et al. 2009). Here, KRT9 is linked to polycystic ovary syndrome.